Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer

Ferroptosis, a form of programed cell death, can be promoted by inhibitors of the xCT transporter (erastin) or GPX4 (RSL3). We found that GPX4, but not the xCT transporter, is selectively elevated in luminal breast cancer. Consistent with this observation, the majority of luminal breast cancer cell...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell death & disease Jg. 14; H. 8; S. 532 - 12
Hauptverfasser:	Park, Soon Young, Jeong, Kang Jin, Poire, Alfonso, Zhang, Dong, Tsang, Yiu Huen, Blucher, Aurora S., Mills, Gordon B.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 18.08.2023 Springer Nature B.V Nature Publishing Group
Schlagworte:	13/1 13/106 13/2 13/31 13/89 14/19 14/34 14/63 38/79 42/41 45/47 631/154/555 631/80/82 64/60 96/2 Antibodies Apoptosis Biochemistry Biomedical and Life Sciences Breast cancer Cancer therapies Cell Biology Cell Culture Cell death Clinical trials DNA damage Enzymes ErbB-2 protein Ferroptosis Humans Immunology Iron Life Sciences Lipid Peroxidation Lipids MCF-7 Cells Membrane Transport Proteins Neoplasms Phosphorylation Proteins Reactive oxygen species S phase Tumor cell lines
ISSN:	2041-4889, 2041-4889
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!